GHK-Cu (Copper Tripeptide-1)

A comprehensive technical summary of the naturally occurring tripeptide GHK (Glycyl-L-Histidyl-L-Lysine) complexed with Copper (II), investigated for its high affinity for copper ions and its role in extracellular matrix remodeling and regenerative signaling pathways.

Peptide Name:
GHK-Cu (Copper Tripeptide-1)
Peptide Sequence
Gly–His–Lys
Complex Type
Tripeptide–Copper (II)
Sequence Length
3 Amino Acids
Primary Research Focus
Extracellular Matrix, Collagen, Tissue Remodeling
Regulatory Status
RUO (Research Use Only)
Molecular Weight
~340 Da (Peptide) / ~404 Da (Complex)
Amino Acid Sequence
Gly–His–Lys (Glycine–Histidine–Lysine)
Structure Note
The histidine residue plays a crucial role in chelating the copper (II) ion, forming the bioactive complex.
Store powder at +4°C (short term) or -20°C (long term). Keep desiccated.
Sterile bacteriostatic water. Preparation should be performed under aseptic conditions. Reconstituted material is not intended for long-term storage.
Structure Note

GHK-Cu is a complex of the tripeptide glycyl-L-histidyl-L-lysine with a copper (II) ion. It was originally isolated from human plasma in the 1970s.

In biological systems, the GHK peptide has a strong affinity for copper, facilitating its transport and uptake into cells. Preclinical research has focused extensively on its ability to modulate the breakdown and synthesis of the extracellular matrix (ECM), particularly collagen, elastin, and glycosaminoglycans, making it a staple in regenerative medicine and dermatological research models.

Note: All findings discussed are preclinical and exploratory. GHK-Cu is not an approved therapeutic drug.

 

The defining characteristic of GHK-Cu in research literature is its interaction with fibroblasts. In vitro studies have demonstrated that the complex can:

  • Upregulate the synthesis of collagen (Type I and III) and elastin

  • Stimulate the production of proteoglycans (e.g., decorin) and glycosaminoglycans

  • Enhance the structural organization of the extracellular matrix in skin models

This anabolic effect on connective tissue components suggests a role in maintaining tissue integrity and mechanical strength.

Beyond synthesis, GHK-Cu is investigated for its regulatory effect on matrix metalloproteinases (MMPs), the enzymes responsible for breaking down ECM.

Research (e.g., Siméon et al.) indicates that GHK-Cu modulates the activity of MMP-2 and MMP-9, as well as their tissue inhibitors (TIMPs). This dual action supports controlled matrix remodeling—facilitating removal of damaged tissue while promoting deposition of new ECM.

Animal models of ischemic and diabetic wounds have been used to evaluate GHK-Cu. Studies report:

  • Improved tissue repair kinetics
  • Enhanced angiogenesis
  • Increased antioxidant enzyme activity

Copper availability is essential for lysyl oxidase activity, which enables collagen cross-linking and maturation.

GHK-Cu has been observed to influence fibroblast secretion of growth factors, including:

  • VEGF (Vascular Endothelial Growth Factor)
  • bFGF (basic Fibroblast Growth Factor)

This paracrine signaling is hypothesized to mediate angiogenic and proliferative effects in tissue culture systems.

Ex vivo human skin explants have been used to explore changes in skin density and thickness markers. Research suggests potential modulation of dermal matrix density and collagen network organization.

Rodent sciatic nerve models suggest GHK-Cu may promote nerve regeneration markers. Proposed mechanisms include increased NGF expression and integrin-mediated axonal outgrowth.

Studies (e.g., Kang et al.) indicate GHK-Cu may restore proliferative capacity in epidermal stem cells through modulation of p63, a transcription factor critical for stem cell maintenance.

Connectivity Map analyses identify GHK as a modulator of gene expression patterns associated with metastatic suppression and tissue integrity. These findings are strictly in-vitro and genomic-correlative.

GHK-Cu exhibits antioxidant behavior by neutralizing lipid peroxidation byproducts and regulating free copper availability, preventing Fenton-reaction–mediated oxidative damage while supporting enzymes such as SOD.

  • Preclinical Nature: Most data derives from in-vitro or animal models

  • Copper Balance: Excess copper is toxic; systemic windows remain undefined

  • Stability: Complexation improves stability, but enzymatic degradation remains a consideration

 

  • Maquart, F. X., et al. (1988) — FEBS Letters
  • Siméon, A., et al. (2000) — Journal of Investigative Dermatology
  • Mulder, G. D., et al. (1994) — Wound Repair and Regeneration
  • Pollard, J. D., et al. (2005) — Archives of Facial Plastic Surgery
  • Kang, Y. A., et al. (2009) — Journal of Investigative Dermatology
The compound listed below is referenced in research contexts related to the mechanisms discussed in this article.
GHK-Cu (Copper Tripeptide) is a chemical reference standard intended strictly for in-vitro and laboratory research applications (e.g., cell culture assays, ECM modeling). It is not a drug, dietary supplement, or food additive. It is not intended for human consumption, injection, or therapeutic use. All handling must be performed by qualified professionals in a laboratory setting.

Hospira Bac Water – 30ml

Kisspeptin

374675-21-5

GLP1-S

910463-68-2

5-Amino-1MQ

42464-96-0

Immune & Inflammatory Signaling Bundle

GH Axis & Endocrine Signaling Bundle

Neuro-Signaling & Neuropeptide Bundle

Mitochondrial & Cellular Energy Bundle

Structural & Cytoskeletal Research Bundle